GWW

GWW Operating Cash Flow (Statement)

$2.18BTTM · USD

Period ending:

GWW FY Cash from OperationsUSD
GWW FY Cash from Operations1989-12-31: $46.90M1990-12-31: $182.80M1991-12-31: $150.60M1992-12-31: $196.40M1993-12-31: $162.50M1994-12-31: $191.40M1995-12-31: $126.30M1996-12-31: $271.40M1997-12-31: $426.10M1998-12-31: $334.60M1999-12-31: $29.70M2000-12-31: $277.76M2001-12-31: $510.79M2002-12-31: $303.47M2003-12-31: $394.11M2004-12-31: $406.49M2005-12-31: $432.54M2006-12-31: $436.75M2007-12-31: $468.88M2008-12-31: $530.48M2009-12-31: $732.40M2010-12-31: $596.45M2011-12-31: $723.69M2012-12-31: $816.20M2013-12-31: $986.50M2014-12-31: $959.81M2015-12-31: $1.01B2016-12-31: $1.00B2017-12-31: $1.06B2018-12-31: $1.06B2019-12-31: $1.04B2020-12-31: $1.12B2021-12-31: $937.00M2022-12-31: $1.33B2023-12-31: $2.03B2024-12-31: $2.11B2025-12-31: $2.02B$2.11B$0.00
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GWW operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

W. W. Grainger Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
2,015,000,000
2,111,000,000
2,031,000,000
1,333,000,000
937,000,000
1,123,000,000
1,042,000,000
1,057,000,000
1,056,557,000
1,002,976,000
1,011,657,000
959,814,000
986,498,000
816,195,000
723,687,000
596,445,000
732,396,000
530,477,000
468,875,000
436,753,000
432,543,000
406,487,000
394,108,000
303,470,000
510,794,000
277,757,000
29,700,000
334,600,000
426,100,000
271,400,000
126,300,000
191,400,000
162,500,000
196,400,000
150,600,000
182,800,000
46,900,000

Compare operating cash flow (statement)

All GWW financial metrics · GWW stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.